Synovial Sarcoma - Pipeline Review, H2 2014 On 30th January 2015
Summary Synovial Sarcoma - Pipeline Review, H2 2014, provides an overview of the Synovial Sarcomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Synovial Sarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Synovial Sarcoma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Browse Full Report @ http://www.jsbmarketresearch.com/healthcare-medical/r-synovial-sarcomapipeline-review-h2-2014-151306
Scope - The report provides a snapshot of the global therapeutic landscape of Synovial Sarcoma - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Synovial Sarcoma and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Synovial Sarcoma products under development by companies and universities/research institutes based on information derived from company and industryspecific sources - Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Synovial Sarcoma pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products
Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Synovial Sarcoma - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Synovial Sarcoma pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Table of Content List of Tables 4 List of Figures 4 Introduction 5 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Global Markets Direct Report Coverage 5 Synovial Sarcoma Overview 6 Therapeutics Development 7 Pipeline Products for Synovial Sarcoma - Overview 7 Pipeline Products for Synovial Sarcoma - Comparative Analysis 8 Synovial Sarcoma - Therapeutics under Development by Companies 9 Synovial Sarcoma - Therapeutics under Investigation by Universities/Institutes 10 Synovial Sarcoma - Pipeline Products Glance 11 Clinical Stage Products 11 Early Stage Products 12 Unknown Stage Products 13 Synovial Sarcoma - Products under Development by Companies 14 Synovial Sarcoma - Products under Investigation by Universities/Institutes 15 Synovial Sarcoma - Companies Involved in Therapeutics Development 16 Adaptimmune Limited 16 Eisai Co., Ltd. 17 Karyopharm Therapeutics, Inc. 18 Merck & Co., Inc. 19 Novartis AG 20 OncoTherapy Science, Inc. 21 Synovial Sarcoma - Therapeutics Assessment 22 Assessment by Monotherapy Products 22 Assessment by Target 23 Assessment by Mechanism of Action 25 Assessment by Route of Administration 27 Assessment by Molecule Type 29 Drug Profiles 31 Cell Therapy to Target NY-ESO-1 and LAGE-1 for Oncology - Drug Profile 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 Dendritic Cell Therapy to Target MAGE-A1, MAGE-A3, and NY-ESO-1 for Oncology - Drug Profile 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
E-7438 - Drug Profile 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 everolimus - Drug Profile 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 OTSA-101 - Drug Profile 41 Product Description 41 Mechanism of Action 41 R&D Progress 41 pembrolizumab - Drug Profile 42 Product Description 42 Mechanism of Action 42 R&D Progress 42 selinexor - Drug Profile 46 Product Description 46 Mechanism of Action 46 R&D Progress 46 SSTC-104 - Drug Profile 50 Product Description 50 Mechanism of Action 50 R&D Progress 50 Synovial Sarcoma - Recent Pipeline Updates 51 Synovial Sarcoma - Discontinued Products 72 Synovial Sarcoma - Product Development Milestones 73 Featured News & Press Releases 73 Oct 17, 2014: Adaptimmune Announces Interim Results from Pilot Trial of its Engineered NYESO T Cells Targeting Synovial Sarcoma 73 Jul 30, 2012: OncoTherapy Science Receives Patent For OTSA101 In Japan And US 75 Oct 16, 2011: OncoTherapy Sciences Subsidiary Receives French Approval For Clinical Trial Of OTSA101 75 Appendix 76 Methodology 76 Coverage 76 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Secondary Research 76 Primary Research 76 Expert Panel Validation 76 Contact Us 77 Disclaimer 77 List Of Tables Number of Products under Development for Synovial Sarcoma, H2 2014 7 Number of Products under Development for Synovial Sarcoma - Comparative Analysis, H2 2014 8 Number of Products under Development by Companies, H2 2014 9 Number of Products under Investigation by Universities/Institutes, H2 2014 10 Comparative Analysis by Clinical Stage Development, H2 2014 11 Comparative Analysis by Early Stage Development, H2 2014 12 Comparative Analysis by Unknown Stage Development, H2 2014 13 Products under Development by Companies, H2 2014 14 Products under Investigation by Universities/Institutes, H2 2014 15 Synovial Sarcoma - Pipeline by Adaptimmune Limited, H2 2014 16 Synovial Sarcoma - Pipeline by Eisai Co., Ltd., H2 2014 17 Synovial Sarcoma - Pipeline by Karyopharm Therapeutics, Inc., H2 2014 18 Synovial Sarcoma - Pipeline by Merck & Co., Inc., H2 2014 19 Synovial Sarcoma - Pipeline by Novartis AG, H2 2014 20 Synovial Sarcoma - Pipeline by OncoTherapy Science, Inc., H2 2014 21 Assessment by Monotherapy Products, H2 2014 22 Number of Products by Stage and Target, H2 2014 24 Number of Products by Stage and Mechanism of Action, H2 2014 26 Number of Products by Stage and Route of Administration, H2 2014 28 Number of Products by Stage and Molecule Type, H2 2014 30 Synovial Sarcoma Therapeutics - Recent Pipeline Updates, H2 2014 51 Synovial Sarcoma - Discontinued Products, H2 2014 72 List Of Figures Number of Products under Development for Synovial Sarcoma, H2 2014 7 Number of Products under Development for Synovial Sarcoma - Comparative Analysis, H2 2014 8 Number of Products under Development by Companies, H2 2014 9 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Comparative Analysis by Clinical Stage Development, H2 2014 11 Assessment by Monotherapy Products, H2 2014 22 Number of Products by Top 10 Targets, H2 2014 23 Number of Products by Stage and Top 10 Targets, H2 2014 24 Number of Products by Top 10 Mechanism of Actions, H2 2014 25 Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 26 Number of Products by Top 10 Routes of Administration, H2 2014 27 Number of Products by Stage and Top 10 Routes of Administration, H2 2014 28 Number of Products by Top 10 Molecule Types, H2 2014 29 Number of Products by Stage and Top 10 Molecule Types, H2 2014 30
Report Price: Licence Type
Price
$ 2000
Site License
$ 4000
Enterprise Wide Licence
$ 6000
Related Reports: Global Geomembranes Market 2015-2019 Global Equine Healthcare Market 2015-2019 Global Fluoropolymer Market in the Healthcare Industry 2015-2019 Global Neurosurgery Market 2015-2019 Global Ankylosing Spondylitis Market 2015-2019 Epilepsy Market in the US 2015-2019 Cigna-HealthSpring : Company Profile and SWOT Analysis Global Radiofrequency Ablation Devices Market 2015-2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Global Hematology Analyzers and Reagents Market 2015-2019 Global Geomembranes Market 2015-2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Synovial Sarcoma - Pipeline Review, H2 2014 http://www.jsbmarketresearch.com/healthcare-medical/r-synovial-sarcomapipeline-review-h2-2014-151306
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/